About Core Clinical Research
Clinical Trials at Core Clinical Research
During the past decade, Core Clinical Research conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 11 clinical trials were completed, i.e. on
average, 35.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 11 clinical trials were completed. i.e. 57.9%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Core Clinical Research" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Forest Laboratories" with 3 trials
sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored and "Allergan"
with 3 trials sponsored. Other sponsors include 12 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Core Clinical Research"
#1 collaborator was "H. Lundbeck A/S" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Core Clinical Research
According to Clinical.Site data, the most researched conditions in "Core Clinical Research" are
"Depressive Disorder, Major" (4 trials), "Bipolar Disorder" (3 trials), "Major Depressive Disorder" (3 trials), "Borderline Personality Disorder" (2 trials) and "Episodic Migraine" (2 trials). Many other conditions were trialed in "Core Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Core Clinical Research
Most popular intervention types in "Core Clinical Research" are "Drug" (31 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "Adhansia XR" (2 trials), "Atogepant" (2 trials), "BI 1358894" (2 trials) and "Brexpiprazole" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Core Clinical Research
The vast majority of trials in "Core Clinical Research" are
31 trials for "All" genders.
Clinical Trials Status at Core Clinical Research
Currently, there are NaN active trials in "Core Clinical Research".
undefined are not yet recruiting,
11 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Core Clinical Research,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Core Clinical Research, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".